H&T Presspart, a Division of the Heitkamp & Thumann Group, have reached agreement with Liberta Partners, a multi-family holding based in Munich, on the acquisition of novelex AG (“novelex”), formerly forteq Nidau AG. novelex is based in Nidau, Switzerland, and focuses on the design, development and manufacturing of plastic components and devices for the Pharmaceutical…
pioneering concepts for
novelex is the preferred industrial partner in design, development and manufacturing of complex complete plastic solutions for the pharmaceutical industry, diagnostics and medical technology. novelex has extensive and longtime experience in the production of systems in injection molding technology.
We offer our customers safe and high-quality complete plastic solutions in the healthcare sector. With state-of-the-art injection molding machines and automated assembly, we guarantee fast cycle times, high accuracy and maximum reliability with the best quality.
novelex develops and produces in clean rooms that meet the requirements of ISO 14644, Class 7 & 8 and EU GMP Class C. We support our customers in the moulding optimized design development of systems in the pharmaceutical industry, medical technology and diagnostics. We accompany you from the basic idea and the conception of your specifications up to the batch production of your product. Of course, we also support you in improving your existing product.
We implement the integration of additional functions or the simplification of the construction and can thus guarantee the best result. The focus is always on increasing the reliability of the product. This is how we offer maximum customer benefit. With our experience in automated production, we ensure efficient and reproducible accuracy of your products. On request, we can take over the external sterilization of your product.
novelex is certified according to EN ISO 13485. The focus of our services and services are the requirements of our customers and those of the law. The further fulfillment of EN ISO 13485, U.S. QSR 21 CFR 820 and GxP, ensures the highest level of product safety for patients and users of the products placed on the market by our customers.
Comprehensive and unambiguous documentation of the product life cycle guarantees clear product traceability through lot numbers. The product lots are continuously checked and approved for compliance with the specification by the quality department using coordinated measurement and test procedures through the IPC tests.